Video

Prostate Cancer Screening and Early Detection, Part III

Continuing the previous discussion on prostate cancer screening, Neal D. Shore, MD, describes how the recent United States Preventive Service Task Force (USPSTF) recommendation on PSA testing has affected his practice. (View other discussions.)

Shore believes the recommendation was made without any forethought to how it would be received and interpreted by the public. As a result, he feels many patients have completely discredited PSA testing, which he does not feel was the goal of the USPSTF decision.

Ultimately, an increase in patients with high-risk factors who do not receive appropriate diagnosis and screening could increase the number of patients presenting with advanced prostate cancer. Shore does not believe a one-size-fits-all recommendation is the best approach and guidance is needed to better determine who should be screened, diagnosed, and biopsied.

In general, panelist Paul R. Sieber, MD, concurs with Shore, adding that the USPSTF recommendation has added an extra burden to his daily practice.

View >>> PSA Screening, Part IView >>> PSA Screening, Part II

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity